Cargando…
Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells
Patients with advanced prostate cancer (PCa) invariably develop resistance to anti-androgen therapy and taxane-based chemotherapy. Glucocorticoid receptor (GR) has been implicated in PCa therapy resistance; however, the mechanisms underlying GR-mediated chemoresistance remain unclear. Lens epitheliu...
Autores principales: | Sanchez-Hernandez, Evelyn S., Ochoa, Pedro T., Suzuki, Tise, Ortiz-Hernandez, Greisha L., Unternaehrer, Juli J., Alkashgari, Hossam R., Diaz Osterman, Carlos J., Martinez, Shannalee R., Chen, Zhong, Kremsky, Isaac, Wang, Charles, Casiano, Carlos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453226/ https://www.ncbi.nlm.nih.gov/pubmed/37626856 http://dx.doi.org/10.3390/cells12162046 |
Ejemplares similares
-
The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells
por: Ortiz-Hernandez, Greisha L., et al.
Publicado: (2021) -
Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance
por: Martinez, Shannalee R., et al.
Publicado: (2023) -
Twenty years of research on the DFS70/LEDGF autoantibody-autoantigen system: many lessons learned but still many questions
por: Ortiz-Hernandez, Greisha L., et al.
Publicado: (2020) -
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
por: Mediavilla-Varela, Melanie, et al.
Publicado: (2009) -
The Nuclear Dense Fine Speckled (DFS) Immunofluorescence Pattern: Not All Roads Lead to DFS70/LEDGFp75
por: Sanchez-Hernandez, Evelyn S., et al.
Publicado: (2023)